Furconazole-cis | CAS#112839-32-4 | fungicide

MedKoo Cat#: 599286 | Name: Furconazole-cis

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Furconazole-cis is a fungicide, bactericide, and wood preservative.

Chemical Structure

Furconazole-cis

CAS#112839-32-4

Theoretical Analysis

MedKoo Cat#: 599286

Name: Furconazole-cis

CAS#: 112839-32-4

Chemical Formula: C15H14Cl2F3N3O2

Exact Mass: 395.0415

Molecular Weight: 396.19

Elemental Analysis: C, 45.47; H, 3.56; Cl, 17.90; F, 14.39; N, 10.61; O, 8.08

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

LS 840606; LS-840606; LS840606; Furconazole-cis;

IUPAC/Chemical Name

rel-1-(((2R,5R)-2-(2,4-dichlorophenyl)-5-(2,2,2-trifluoroethoxy)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole

InChi Key

ULCWZQJLFZEXCS-KGLIPLIRSA-N

InChi Code

InChI=1S/C15H14Cl2F3N3O2/c16-10-1-2-11(12(17)5-10)14(6-23-9-21-8-22-23)4-3-13(25-14)24-7-15(18,19)20/h1-2,5,8-9,13H,3-4,6-7H2/t13-,14+/m1/s1

SMILES Code

FC(F)(F)CO[C@H]1CC[C@](CN2N=CN=C2)(C3=CC=C(Cl)C=C3Cl)O1

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 396.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Wang J, Zhan P, Zhou R, Xu J, Shao X, Yang Y, Ouyang J. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials. Med Oncol. 2010 Dec;27(4):1082-8. doi: 10.1007/s12032-009-9339-0. Epub 2009 Oct 30. PubMed PMID: 19876778. 2: Taylor JE, Tan K, Lai NM, McDonald SJ. Antibiotic lock for the prevention of catheter-related infection in neonates. Cochrane Database Syst Rev. 2015 Jun 4;(6):CD010336. doi: 10.1002/14651858.CD010336.pub2. Review. PubMed PMID: 26040840. 3: Atanasova I, Bozhinova K, Terziivanov D. Average bioequivalence of two oral formulations of fluconazole in healthy subjects after multiple dosing. Int J Clin Pharmacol Ther. 1999 Jun;37(6):282-5. PubMed PMID: 10395119. 4: Jovanović D, Kilibarda V, Cirić B, Vucinić S, Srnić D, Vehabović M, Potogija N. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. Clin Ther. 2005 Oct;27(10):1588-95. PubMed PMID: 16330294. 5: Gafter-Gvili A, Vidal L, Goldberg E, Leibovici L, Paul M. Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clin Proc. 2008 Sep;83(9):1011-21. doi: 10.4065/83.9.1011. Review. PubMed PMID: 18775201. 6: Hiller D, Stahl S, Morschhäuser J. Multiple cis-acting sequences mediate upregulation of the MDR1 efflux pump in a fluconazole-resistant clinical Candida albicans isolate. Antimicrob Agents Chemother. 2006 Jul;50(7):2300-8. PubMed PMID: 16801405; PubMed Central PMCID: PMC1489804. 7: Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome. J Antimicrob Chemother. 2008 Dec;62(6):1379-85. doi: 10.1093/jac/dkn381. Epub 2008 Sep 8. PubMed PMID: 18782778. 8: Cavaleiro C, Salgueiro L, Gonçalves MJ, Hrimpeng K, Pinto J, Pinto E. Antifungal activity of the essential oil of Angelica major against Candida, Cryptococcus, Aspergillus and dermatophyte species. J Nat Med. 2015 Apr;69(2):241-8. doi: 10.1007/s11418-014-0884-2. Epub 2015 Jan 10. PubMed PMID: 25576097. 9: Lo Re V 3rd, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Haynes K, Roy JA, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA. Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status. Am J Med. 2016 Mar;129(3):283-91.e5. doi: 10.1016/j.amjmed.2015.10.029. Epub 2015 Nov 17. PubMed PMID: 26597673; PubMed Central PMCID: PMC5549881. 10: Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog. 2009 Jan;5(1):e1000268. doi: 10.1371/journal.ppat.1000268. Epub 2009 Jan 16. PubMed PMID: 19148266; PubMed Central PMCID: PMC2607542. 11: Zhu SL, Yan L, Zhang YX, Jiang ZH, Gao PH, Qiu Y, Wang L, Zhao MZ, Ni TJ, Cai Z, Tian SJ, Zang CX, Zhang DZ, Jiang YY. Berberine inhibits fluphenazine-induced up-regulation of CDR1 in Candida albicans. Biol Pharm Bull. 2014;37(2):268-73. PubMed PMID: 24492724. 12: Arai M, Harasaki T, Fukuoka T, Kaneko S, Konosu T. Synthesis and evaluation of novel pyrrolidinyl sordaricin derivatives as antifungal agents. Bioorg Med Chem Lett. 2002 Oct 7;12(19):2733-6. PubMed PMID: 12217365. 13: Venkatesh M, Rong L, Raad I, Versalovic J. Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol. 2009 Jul;58(Pt 7):936-44. doi: 10.1099/jmm.0.009761-0. Epub 2009 Jun 5. PubMed PMID: 19502361. 14: Yang J, Xie RH, Krewski D, Wang YJ, Walker M, Wen SW. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. Int J Infect Dis. 2011 May;15(5):e336-41. doi: 10.1016/j.ijid.2011.01.007. Epub 2011 Feb 22. PubMed PMID: 21345707. 15: Kumar RS, Arunachalam S. Synthesis, micellar properties, DNA binding and antimicrobial studies of some surfactant-cobalt(III) complexes. Biophys Chem. 2008 Aug;136(2-3):136-44. doi: 10.1016/j.bpc.2008.05.007. Epub 2008 Jun 5. PubMed PMID: 18571829. 16: Hammami MM, De Padua SJS, Hussein R, Al Gaai E, Khodr NA, Al-Swayeh R, Alvi SN, Binhashim N. Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs. BMC Pharmacol Toxicol. 2017 Dec 8;18(1):78. doi: 10.1186/s40360-017-0182-1. PubMed PMID: 29216899; PubMed Central PMCID: PMC5721559. 17: Koch M, Trapp R, Goepel M. Successful maintenance of continuous ambulatory peritoneal dialysis in a patient after fungal peritonitis and dialysate leakage. Clin Nephrol. 2006 Apr;65(4):294-8. PubMed PMID: 16629231. 18: Dupont H, Mahjoub Y, Chouaki T, Lorne E, Zogheib E. Antifungal Prevention of Systemic Candidiasis in Immunocompetent ICU Adults: Systematic Review and Meta-Analysis of Clinical Trials. Crit Care Med. 2017 Nov;45(11):1937-1945. doi: 10.1097/CCM.0000000000002698. Review. PubMed PMID: 28857851. 19: Eshun-Wilson I, Okwen MP, Richardson M, Bicanic T. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. Cochrane Database Syst Rev. 2018 Jul 24;7:CD009012. doi: 10.1002/14651858.CD009012.pub3. Review. PubMed PMID: 30039850. 20. Error occurred: cannot get document summary PMID: 30089646